NasdaqCM - Delayed Quote USD
Revelation Biosciences, Inc. (REVB)
0.8230
-0.0270
(-3.18%)
At close: June 2 at 4:00:00 PM EDT
1.0200
+0.20
+(23.94%)
Pre-Market: 4:39:31 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-18,277.7140
-18,321.2760
-7,286.2860
-11,219.3960
-11,090.5730
Investing Cash Flow
0.0010
-19.1710
0
0
-131.9630
Financing Cash Flow
7,430.5840
12,847.7640
14,025.0080
15,197.6460
8,004.8650
End Cash Position
3,704.6110
6,499.0180
11,991.7010
5,252.9790
1,274.7290
Capital Expenditure
--
-19.1710
--
--
-131.9630
Issuance of Capital Stock
0
5,417.0530
14,029.9740
4,456.0480
8,004.8650
Issuance of Debt
--
--
0
2,500
0
Repayment of Debt
--
--
0
-3,296.8820
0
Repurchase of Capital Stock
--
0
-5
--
--
Free Cash Flow
-18,277.7130
-18,340.4470
-7,286.2860
-11,219.3960
-11,222.5360
12/31/2021 - 11/17/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PALI Palisade Bio, Inc.
0.7600
+2.43%
CDT Conduit Pharmaceuticals Inc.
3.9400
+21.23%
TOVX Theriva Biologics, Inc.
0.4886
+4.65%
AEON AEON Biopharma, Inc.
0.5506
-4.41%
PSTV Plus Therapeutics, Inc.
0.3677
+28.16%
QNRX Quoin Pharmaceuticals, Ltd.
8.74
+3.05%
CERO CERo Therapeutics Holdings, Inc.
0.4467
+0.29%
XLO Xilio Therapeutics, Inc.
0.7001
-34.57%
ENSC Ensysce Biosciences, Inc.
2.2200
0.00%
ZVSA ZyVersa Therapeutics, Inc.
0.6563
+4.37%